Candel Therapeutics Inc (NQ: CADL )
5.160
-0.090
(-1.71%)
Streaming Delayed Price
Updated: 12:02 PM EDT, Aug 21, 2024
Add to My Watchlist
Headline News about Candel Therapeutics Inc
![](https://cdn.benzinga.com/files/images/story/2023/04/10/tupperware_brands_-_logo.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Candel Therapeutics's Return On Capital Employed Insights
March 31, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1523.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Intraday Session
January 23, 2023
Via Benzinga
Candel Therapeutics Earnings Perspective: Return On Capital Employed
December 20, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_2109.jpeg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_23722.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Friday's After-Market Session
December 16, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_8517.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For December 2, 2022
December 02, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_19708.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/24/image_4.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_19673.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_19658.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/20/shutterstock_306271739.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/15/bz-pharma_2.jpg?width=1200&height=800&fit=crop)
Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary
September 15, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/15/bz-pharma_1.jpg?width=1200&height=800&fit=crop)
Candel Secures European Medicines Agency Orphan Drug Status For Brain Tumour Candidate
September 15, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_2784.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_15563.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/27/yesterdays_movers.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/20/yesterdays_movers.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/19/mid-day_movers_image_0.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_3169.jpeg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_387.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech_4.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_316.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_21.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_290.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-afternoon-market-update_23.jpg)
Mid-Afternoon Market Update: Kadmon Surges Following Acquisition News; UiPath Shares Drop
September 08, 2021
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_285.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day-market-update_21.jpg)
Mid-Day Market Update: Crude Oil Rises 1%; REV Group Shares Plummet
September 08, 2021
Via Benzinga
Topics
Stocks
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.